https://www.fhi.no/en/publ/2021/Ofatumumab-treatment-RRMS/
Ofatumumab for the treatment of relapsing remitting multiple sclerosis: a rapid health technology...
We have conducted a rapid health technology assessment (HTA) of ofatumumab to treat of adults with relapsing remitting multiple sclerosis (RRMS) on behalf of...
https://www.linkos.cz/lekar-a-multidisciplinarni-tym/kongresy/po-kongresu/databaze-tuzemskych-onkologickych-konferencnich-abstrakt/final-analysis-from-the-international-trial-of-single-agent-ofatumumab-in-patien/
Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with...
https://www.linkos.cz/lekar-a-multidisciplinarni-tym/kongresy/po-kongresu/databaze-tuzemskych-onkologickych-konferencnich-abstrakt/correlations-between-ofatumumab-exposure-and-treatment-outcomes-for-patients-wit/
Correlations Between Ofatumumab Exposure and Treatment Outcomes for Patients with Chronic...
for patients withtreatment outcomescorrelationsofatumumabexposure
https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Real-world-Australian-experience-with-Ofatumumab-in/991005723868107891
Real-world Australian experience with Ofatumumab in the MSBase Registry - Murdoch University
Real-world Australian experience with Ofatumumab in the MSBase Registry - Murdoch University - Journal article
real world
https://ctv.veeva.com/study/recombinant-human-il-18-and-ofatumumab-after-pbsct-for-lymphoma
Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma
The purpose of this study is to test the safety of rhIL-18 combined with ofatumumab to see what effects (good and bad) it has on subjects and their...
recombinanthumanilofatumumablymphoma